Cytophage Strengthens Board of Directors

Winnipeg, May 27, 2024. Cytophage Technologies Ltd. (TSXV:CYTO) (“Cytophage” or the “Company”), the only publicly traded phage company that is focused on bacteriophage solutions for both animal health and human health, is pleased to announce that it has strengthened its board of directors with the addition of John Snisarenko, a 30+ year veteran of, and seasoned C-Suite executive in, the pharmaceutical and biotech industries.

We can win the war against battlefield infection.
Cytophage was selected for the Defense Innovation Award 2019.

Winner of 2018 Nutreco Feed Tech Challenge
For our breakthrough innovation to help feed the world.

Swine Bacteriophage

We’re helping farmers meet the need and the demand for a healthier food chain.

Funded in part by the Canada and Manitoba governments through the Canadian Agricultural Partnership – Ag Action Manitoba Program. Learn more

Contact Us

Learn more about our bacteriophage solutions.

Cytophage Technologies Ltd. © 2019